To investigate the molecular mechanisms underlying suppression of AML progression mediated by Fbxo22 deficiency, we explored the interactome of FBXO22 in THP-1 cells by immunoprecipitation (IP) combined with LC-MS/MS analysis. The gene discussed is FBXO22; the disease is acute myeloid leukemia.